Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
Systematic localization of common disease-associated variation in regulatory DNA.
Practical medical applications of quantitative MR relaxometry.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Fat-soluble vitamins as disease modulators in multiple sclerosis.
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
New management algorithms in multiple sclerosis.
Alemtuzumab: The advantages and challenges of a novel therapy in MS.
Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.
Fingolimod-Associated Peripheral Vascular Adverse Effects.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Vitamin D status and ill health: a systematic review.
Callosal atrophy in multiple sclerosis is related to cognitive speed.
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients.

Pages